Human GITR / TNFRSF18 Protein (His Tag, ECD)
AITR,CD357,GITR,GITR-D
- 100ug (NPP1547) Please inquiry
| Catalog Number | P13643-H08H |
|---|---|
| Organism Species | Human |
| Host | Human Cells |
| Synonyms | AITR,CD357,GITR,GITR-D |
| Molecular Weight | The recombinant human TNFRSF18 consists 147 amino acids and predicts a molecular mass of 16 kDa. |
| predicted N | Gln 26 |
| SDS-PAGE | ![]() |
| Purity | > 90 % as determined by SDS-PAGE. |
| Protein Construction | A DNA sequence encoding the human TNFRSF18 (NP_683700.1) (Met1-Glu161) was expressed with a polyhistidine tag at the C-terminus. |
| Bio-activity | |
| Research Area | Signaling |Signal Transduction |Growth Factor & Receptor |Tumor Necrosis Factor (TNF) & Receptor |TNF Receptor |
| Formulation | Lyophilized from sterile PBS, pH 7.4. 1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
| Background | GITR, also known as TNFRSF18(CD357), belongs to the tumor necrosis factor receptor (TNF-R) superfamily. It is the receptor for TNFSF18. GITR plays a key role in dominant immunological self-tolerance maintained by CD25(+)CD4(+) regulatory T cells. GITR may be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. GITR and its ligand are important costimulatory molecules in the pathogenesis of autoimmune diseases. It also mediates NF-kappa-B activation via the TRAF2/NIK pathway. |
| Reference |

